Zenas BioPharma, Inc. (ZBIO), Monday announced the appointment of Lisa von Moltke as the company's Head of Research and Development and Chief Medical Officer.
Most recently, von Moltke served as CMO at Seres Therapeutics with functional oversight of clinical development, sciences and operations, and regulatory and medical affairs.
Friday, Zenas's stock closed at $8.25, down 5.50 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.